Bendamustine and Cellulitis for Men aged 60+ (a phase IV clinical study of FDA data)

Summary:

Cellulitis is found for men aged 60+ who take Bendamustine (bendamustine). This study is created by eHealthMe based on reports of 2,280 men aged 60+ from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

  • Time on Bendamustine when people have Cellulitis
  • Top conditions
  • Top co-used drugs
  • Top other side effects

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 22, 2026

2,280 men aged 60+ reported to have side effects when taking Bendamustine.
Among them, 3 people (0.13%) have Cellulitis


What is Bendamustine?

Bendamustine has active ingredients of bendamustine. eHealthMe is studying from 9,508 Bendamustine users. Check the latest studies of Bendamustine.

What is Cellulitis?

Cellulitis (infection under the skin) is found to be associated with 2,081 drugs and 2,340 conditions by eHealthMe. Check the latest studies of Cellulitis.

Number of reports submitted per year:

Could Bendamustine cause Cellulitis in men aged 60+?

Time on Bendamustine when people have Cellulitis *

  • < 1 month: 33.33 %
  • 1 - 6 months: 66.67 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Severity of Cellulitis

n/a

How people recovered from Cellulitis

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

  1. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 3 people, 100.00%
  2. Stress And Anxiety: 1 person, 33.33%
  3. Pain: 1 person, 33.33%
  4. Hypokalemia (low potassium): 1 person, 33.33%
  5. High Blood Pressure: 1 person, 33.33%
  6. Depression: 1 person, 33.33%
  7. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 33.33%
  8. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 33.33%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

  1. Xarelto: 1 person, 33.33%
  2. Turmeric: 1 person, 33.33%
  3. Polivy: 1 person, 33.33%
  4. Oxycodone: 1 person, 33.33%
  5. Ondansetron: 1 person, 33.33%
  6. Morphine: 1 person, 33.33%
  7. Methylprednisolone: 1 person, 33.33%
  8. Gazyva: 1 person, 33.33%
  9. Etoposide: 1 person, 33.33%
  10. Cytarabine: 1 person, 33.33%

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

  1. Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 66.67%
  2. Tumor Lysis Syndrome: 1 person, 33.33%
  3. Lung Neoplasm (tumour of lung): 1 person, 33.33%
  4. Disease Progression: 1 person, 33.33%
  5. Drug Ineffective: 1 person, 33.33%
  6. Escherichia Infection (bacterial infection by escherichia coli): 1 person, 33.33%
  7. Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 33.33%
  8. Hypercalcaemia (elevated calcium (ca+) level in the blood): 1 person, 33.33%
  9. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 33.33%
  10. Lymphoma (cancer that begins in immune system cells): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Bendamustine and have Cellulitis?

- Check whether Cellulitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.



Related publications that referenced our studies:

Related studies:

How the study uses the data?

The study is based on (applicable) gender, age, bendamustine (the active ingredients of Bendamustine) and Bendamustine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: